SMMT logo

Summit Therapeutics (SMMT)

Profile

Full Name

Summit Therapeutics Inc.

Ticker Symbol

SMMT

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

March 5, 2015

Indexes

Not included

Website

http://www.smmttx.com

Employees

159

Key Details

Price

$21.28(+3.30%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.31(+68.69% YoY)

PE ratio

-

Next earnings date

Aug 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $21.28
    SMMT price is $21.28

    30-Day Relative Volume

    0.47
    SMMT 30-day relative volume is 0.47

    Price Performance

    Price Most recent change

    +3.3%
    SMMT price was up +3.3% on Jun 30, 2025

    Price YTD change

    +19.25%
    SMMT price is up +19.25% since January 1st

    Price 1-year change

    +172.82%
    SMMT price is up +172.82% year-on-year

    Price 3-year change

    +2028%
    SMMT price is up +2028% over the past 3 years

    Price Range

    Price All-time high

    $36.91
    SMMT price is currently -42.35% below its historical high of $36.91

    Price 3-year low

    $0.66
    SMMT price is currently +3124.24% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $15.80B
    SMMT market capitalization is $15.80 billion

    Market cap 3-year change

    +16006.34%
    SMMT market capitalization is up +16006.34% over the past 3 years

    Market cap All-time high

    $27.26B
    SMMT market capitalization is currently -42.02% below its historical high of $27.26 billion

    Market cap sector rank

    94.76%
    SMMT market capitalization is higher than 94.76% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +2.55%
    SMMT shares outstanding is up +2.55% year-on-year

    Shares Outstanding 3-Year Change

    +656.88%
    SMMT shares outstanding is up +656.88% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.75
    SMMT beta is 1.75

    200-day SMA

    $21.01
    SMMT price is currently +1.28% above its 200-day simple moving average

    50-day SMA

    $23.38
    SMMT price is currently -8.98% below its 50-day simple moving average

    RSI

    49.40
    SMMT 14-day relative strength index is 49.40

    Volume

    0.47
    SMMT 30-day relative volume is 0.47

    ATR

    $1.36
    SMMT average true range is $1.36

    10-day Historical Volatility

    31.00%
    SMMT 10-day historical volatility is 31.00%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    SMMT annual revenue value is unknown

    Revenue Analysts estimate

    -
    SMMT annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -
    SMMT annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    SMMT annual revenue is unknown

    EPS

    EPS

    -$0.31
    SMMT annual earnings per share is -$0.31

    EPS Analysts estimate

    -$0.30
    SMMT annual earnings per share is currently +4.87% higher than the consensus analysts' forecast

    EPS 1-year change

    +68.69%
    SMMT annual earnings per share is up +68.69% year-on-year

    EPS Sector rank

    73.15%
    SMMT annual earnings per share is higher than 73.15% of companies in Healthcare sector

    Profit

    Gross profit

    -
    SMMT annual gross profit value is unknown

    Gross margin

    -
    SMMT annual gross profit margin value is unknown

    Operating profit

    -$225.97M
    SMMT annual operating income is -$225.97 million

    Operating margin

    -
    SMMT annual operating profit margin value is unknown

    Net income

    -$221.31M
    SMMT annual net profit is -$221.31 million

    Net margin

    -
    SMMT annual net profit margin value is unknown

    Expenses

    Total expenses

    $225.97M
    SMMT annual total expenses is $225.97 million

    Operating expenses

    $225.97M
    SMMT annual total operating expenses is $225.97 million

    Cost of goods sold

    -
    SMMT annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $60.50M
    SMMT annual SGA is $60.50 million

    Depreciation and amortization

    $89.00K
    SMMT annual depreciation & amortization is $89.00 thousand

    Interest expense

    $8.69M
    SMMT annual interest expense is $8.69 million

    Income tax

    -
    SMMT annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$212.60M
    SMMT annual earnings before interest & taxes is -$212.60 million

    EBITDA

    -$212.51M
    SMMT annual EBITDA is -$212.51 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $435.56M
    SMMT annual total assets is $435.56 million

    Non current assets

    $11.81M
    SMMT annual long term assets is $11.81 million

    Current assets

    $423.75M
    SMMT annual total current assets is $423.75 million

    Cash and cash equivalents

    $104.86M
    SMMT annual cash & cash equivalents is $104.86 million

    Accounts receivable

    -
    SMMT annual accounts receivable value is unknown

    Inventory

    -
    SMMT annual inventory value is unknown

    Liabilities

    Total liabilities

    $46.81M
    SMMT annual total liabilities is $46.81 million

    Long term liabilities

    $5.08M
    SMMT annual total long term liabilities is $5.08 million

    Current liabilities

    $41.73M
    SMMT annual total current liabilities is $41.73 million

    Accounts payable

    $4.64M
    SMMT annual accounts payable is $4.64 million

    Debt

    Total debt

    $7.22M
    SMMT annual total debt is $7.22 million

    Total debt 1-year change

    -93.2%
    SMMT annual total debt is down -93.2% year-on-year

    Long term debt

    $3.45M
    SMMT annual long term debt is $3.45 million

    Short term debt

    $3.77M
    SMMT annual short term debt is $3.77 million

    Equity & Capital

    Shareholders equity

    $388.75M
    SMMT annual stockholders equity is $388.75 million

    Book value

    $388.75M
    SMMT annual book value is $388.75 million

    Retained earnings

    -$1.21B
    SMMT annual retained earnings is -$1.21 billion

    Working capital

    $382.02M
    SMMT annual working capital is $382.02 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$142.11M
    SMMT annual cash flow from operations is -$142.11 million

    Cash from operations 1-year change

    -85.13%
    SMMT annual cash flow from operations is down -85.13% year-on-year

    Cash from investing

    -$205.34M
    SMMT annual cash flow from investing activities is -$205.34 million

    Cash from investing 1-year change

    +65.06%
    SMMT annual cash flow from investing activities is up +65.06% year-on-year

    Cash from financing

    $381.23M
    SMMT annual cash flow from financing activities is $381.23 million

    Cash from financing 1-year change

    +340.66%
    SMMT annual cash flow from financing activities is up +340.66% year-on-year

    CAPEX

    CAPEX

    -
    SMMT annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    SMMT annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$142.25M
    SMMT annual free cash flow is -$142.25 million

    Free cash flow 1-year change

    -85%
    SMMT annual free cash flow is down -85% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    SMMT annual gross profit margin value is unknown

    Operating margin

    -
    SMMT annual operating profit margin value is unknown

    Net margin

    -
    SMMT annual net profit margin value is unknown

    ROA & ROE

    ROA

    -50.81%
    SMMT annual return on assets is -50.81%

    ROE

    -56.93%
    SMMT annual return on equity is -56.93%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    SMMT price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    SMMT price to earnings ratio is unknown

    PB Ratio

    PB ratio

    45.90
    SMMT price to book ratio is 45.90

    PB ratio Sector rank

    98.12%
    SMMT price to book ratio is higher than 98.12% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    SMMT price to sales ratio value is unknown

    PS ratio Sector rank

    -
    SMMT price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $15.60B
    SMMT enterprise value is $15.60 billion

    Enterprise value Sector rank

    93.82%
    SMMT enterprise value is higher than 93.82% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -66.36
    SMMT EV/EBITDA is -66.36

    EV/EBITDA Sector rank

    2.79%
    SMMT EV/EBITDA is higher than 2.79% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    10.15
    SMMT annual current ratio is 10.15

    Quick ratio

    -
    SMMT annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.02
    SMMT annual debt to equity ratio is 0.02

    Interest coverage ratio

    -24.48
    SMMT annual interest coverage ratio is -24.48

    Risk & Stability

    Piotroski F-Score

    -
    SMMT piotroski f-score value is unknown

    Altman Z-Score

    -
    SMMT altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    Jun 11, 25 Leerink Partners
    Underperform
    Jun 2, 25 JMP Securities
    Market Outperform
    May 2, 25 Goldman Sachs
    Buy
    Apr 28, 25 JMP Securities
    Market Outperform
    Apr 25, 25 Jefferies
    Buy
    Apr 23, 25 Cantor Fitzgerald
    Overweight
    Mar 26, 25 Citigroup
    Buy
    Mar 21, 25 Cantor Fitzgerald
    Overweight
    Mar 12, 25 Evercore ISI Group
    Outperform
    Feb 28, 25 Goldman Sachs
    Buy

    Institutional Ownership

    Screeners with SMMT included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    • What is the ticker symbol for Summit Therapeutics?
    • Does Summit Therapeutics pay dividends?
    • What sector is Summit Therapeutics in?
    • What industry is Summit Therapeutics in?
    • What country is Summit Therapeutics based in?
    • When did Summit Therapeutics go public?
    • Is Summit Therapeutics in the S&P 500?
    • Is Summit Therapeutics in the NASDAQ 100?
    • Is Summit Therapeutics in the Dow Jones?
    • When was Summit Therapeutics's last earnings report?
    • When does Summit Therapeutics report earnings?
    • Should I buy Summit Therapeutics stock now?

    What is the ticker symbol for Summit Therapeutics?

    The ticker symbol for Summit Therapeutics is NASDAQ:SMMT

    Does Summit Therapeutics pay dividends?

    No, Summit Therapeutics does not pay dividends

    What sector is Summit Therapeutics in?

    Summit Therapeutics is in the Healthcare sector

    What industry is Summit Therapeutics in?

    Summit Therapeutics is in the Biotechnology industry

    What country is Summit Therapeutics based in?

    Summit Therapeutics is headquartered in United States

    When did Summit Therapeutics go public?

    Summit Therapeutics's initial public offering (IPO) was on March 5, 2015

    Is Summit Therapeutics in the S&P 500?

    No, Summit Therapeutics is not included in the S&P 500 index

    Is Summit Therapeutics in the NASDAQ 100?

    No, Summit Therapeutics is not included in the NASDAQ 100 index

    Is Summit Therapeutics in the Dow Jones?

    No, Summit Therapeutics is not included in the Dow Jones index

    When was Summit Therapeutics's last earnings report?

    Summit Therapeutics's most recent earnings report was on May 1, 2025

    When does Summit Therapeutics report earnings?

    The next expected earnings date for Summit Therapeutics is Aug 6, 2025

    Should I buy Summit Therapeutics stock now?

    As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page